In Situ Immune Response after Neoadjuvant Chemotherapy for Breast Cancer Predicts Survival

被引：0
|
作者：
Ladoire, S. [1 ]
Coudert, B. [1 ]
Fumoleau, P. [1 ]
Arnould, L. [1 ]
Ghiringhelli, F. [1 ]
机构：
[1] Ctr GF Leclerc, Dijon, France
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-PD07-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD07-05
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Posttherapy Nodal Status, Not Graded Histologic Response, Predicts Survival after Neoadjuvant Chemotherapy for Advanced Gastric Cancer
    Kazumasa Fujitani
    Masayuki Mano
    Motohiro Hirao
    Yoshinori Kodama
    Toshimasa Tsujinaka
    Annals of Surgical Oncology, 2012, 19 : 1936 - 1943
  • [32] The response to neoadjuvant chemotherapy predicts clinical outcome and increases breast conservation in advanced breast cancer
    Spanheimer, Philip M.
    Carr, Jennifer C.
    Thomas, Alexandra
    Sugg, Sonia L.
    Scott-Conner, Carol E. H.
    Liao, Junlin
    Weigel, Ronald J.
    AMERICAN JOURNAL OF SURGERY, 2013, 206 (01): : 2 - 7
  • [33] Breast Cancer Index Predicts Likelihood of Breast Conservation Surgery after Neoadjuvant Chemotherapy.
    Mazouni, C.
    Mathieu, M-C
    Kesty, N. C.
    Zhang, Y.
    Scott, V.
    Schnabel, C. A.
    Erlander, M. G.
    Delaloge, S.
    Andre, F.
    CANCER RESEARCH, 2011, 71
  • [34] Pathologic Response After Neoadjuvant Chemotherapy Predicts Locoregional Control in Patients With Triple-Negative Breast Cancer
    Gillespie, E.
    Chen, V. E.
    Murphy, J.
    Yashar, C. M.
    Lu, S. M.
    Einck, J. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S241 - S241
  • [35] F-18 Fluorodeoxyglucose uptake predicts pathological complete response after neoadjuvant chemotherapy for breast cancer
    Jin, Soyoung
    Kim, Sung-Bae
    Ahn, Jin Hee
    Jung, Kyung Hae
    Ahn, Sei Hyun
    Lee, Jong Won
    Gong, Gyungyub
    Kim, Hye Ok
    Ryu, Jin-Sook
    Moon, Dae Hyuk
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [36] Tumor Response Ratio Better Predicts Overall Survival in Neoadjuvant Chemotherapy Patients With Non-Metastatic Breast Cancer
    Miller, Marian
    Ottesen, Rebecca
    Niland, Joyce
    Kruper, Laura L.
    Chen, Steven L.
    Vito, Courtney
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 81 - 82
  • [37] Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer
    Canteros, Daniel
    Walbaum, Benjamin
    Cordova-Delgado, Miguel
    Torrealba, Andres
    Reyes, Constanza
    Elena Navarro, Maria
    Razmilic, Dravna
    Camus, Mauricio
    Dominguez, Francisco
    Navarrete, Orieta
    Pinto, Mauricio P.
    Pizarro, Gonzalo
    Acevedo, Francisco
    Sanchez, Cesar
    ECANCERMEDICALSCIENCE, 2022, 16
  • [38] MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy
    Mette S. van Ramshorst
    Claudette E. Loo
    Emilie J. Groen
    Gonneke H. Winter-Warnars
    Jelle Wesseling
    Frederieke van Duijnhoven
    Marie-Jeanne T. Vrancken Peeters
    Gabe S. Sonke
    Breast Cancer Research and Treatment, 2017, 164 : 99 - 106
  • [39] Young age: predicts poor response rate after neoadjuvant chemotherapy in endocrine-responsive breast cancer
    Kim, M. K.
    Noh, D-Y
    Han, W.
    Moon, H-G
    Ahn, S-K
    Kim, J. S.
    Kim, T.
    Kim, J. Y.
    Lee, J. W.
    CANCER RESEARCH, 2012, 72
  • [40] MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy
    van Ramshorst, Mette S.
    Loo, Claudette E.
    Groen, Emilie J.
    Winter-Warnars, Gonneke H.
    Wesseling, Jelle
    van Duijnhoven, Frederieke
    Peeters, Marie-Jeanne T. Vrancken
    Sonke, Gabe S.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (01) : 99 - 106
12345